How is beta‑thalassemia diagnosed and what specific tests are used?

Diagnosis usually starts with a complete blood count (CBC) showing low hemoglobin and microcytic, hypochromic red cells. If beta‑thalassemia is suspected, a hemoglobin electrophoresis or high‑performance liquid chromatography (HPLC) is performed to identify abnormal hemoglobin variants. Genetic testing—sequencing the HBB gene—confirms the specific mutation and distinguishes between β⁺ and β⁰ forms.

What are the main treatment options for someone with β⁰ or β⁺ thalassemia, and how do they differ?

For β⁰ thalassemia, regular red‑cell transfusions are usually required to maintain adequate hemoglobin and prevent complications. β⁺ thalassemia may be managed with less frequent transfusions or, in milder cases, with iron‑chelation therapy alone. Both approaches aim to keep hemoglobin above 10–11 g/dL and to avoid iron overload, which is monitored by serum ferritin and liver MRI.

Can a person with beta‑thalassemia have children without passing the disease, and what genetic counseling steps should be taken?

Beta‑thalassemia is inherited in an autosomal recessive pattern. If both parents carry a mutation, each child has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected. Genetic counseling can provide carrier testing for family members, discuss prenatal testing options (amniocentesis or chorionic villus sampling), and explain pre‑implantation genetic diagnosis (PGD) for couples who wish to avoid affected offspring.

What early signs should I look for that might indicate beta‑thalassemia in a child?

Common early signs include unexplained fatigue, pale skin, shortness of breath, and a persistent feeling of weakness. In infants, you might notice poor weight gain, delayed growth, or a swollen abdomen due to an enlarged spleen. If you observe any of these symptoms, especially if they persist or worsen, schedule a blood test to check hemoglobin levels and red blood cell indices.

HBB gene

The HBB gene provides instructions for making beta-globin, a critical component of hemoglobin that allows red blood cells to transport oxygen throughout the body.

Normal Function

The HBB gene provides instructions for making a protein called beta-globin. Beta-globin is a component (subunit) of a larger protein called hemoglobin, which is located inside red blood cells. In adults, hemoglobin typically consists of four protein subunits: two subunits of beta-globin and two subunits of a protein called alpha-globin, which is produced from another gene called HBA. Each of these protein subunits is attached (bound) to an iron-containing molecule called heme; the iron in the center of each heme can bind to one oxygen molecule. The hemoglobin within red blood cells binds to oxygen molecules in the lungs. The red blood cells then travel through the bloodstream and deliver oxygen to tissues throughout the body.

Health Conditions Related to Genetic Changes

Beta thalassemia

Hundreds of HBB gene variants (also called mutations) have been found to cause beta thalassemia. Most of the variants involve a change in a single DNA building block (nucleotide) within or near the HBB gene. Other variants insert or delete a small number of nucleotides in the HBB gene.

HBB gene variants that decrease beta-globin production cause a condition called beta-plus (β+) thalassemia. Variants that prevent cells from producing any beta-globin cause beta-zero (β0) thalassemia.

Low levels of beta-globin can impact the production of hemoglobin. A lack of hemoglobin disrupts the normal development of red blood cells. A shortage of mature red blood cells can greatly reduce the amount of oxygen that is delivered to tissues. A lack of oxygen in the body's tissues can lead to poor growth, organ damage, and other health problems associated with beta thalassemia.

Methemoglobinemia, beta-globin type

Variants in the HBB gene have been found to cause methemoglobinemia, beta-globin type, which is a condition that alters the hemoglobin within red blood cells. These variants often affect the region of the protein that binds to heme. For hemoglobin to bind to oxygen, the iron within the heme molecule needs to be in a form called ferrous iron (Fe2+). The iron within heme can change to another form of iron called ferric iron (Fe3+), which cannot bind to oxygen. Hemoglobin that contains ferric iron is known as methemoglobin and is unable to efficiently deliver oxygen to the body's tissues.

In people with methemoglobinemia, beta-globin type, variants in the HBB gene alter the beta-globin protein and cause the heme iron to change from ferrous to ferric. This altered hemoglobin gives the blood a brown color and causes the skin, lips, and nails to appear bluish in color (cyanosis). The signs and symptoms of methemoglobinemia, beta-globin type are generally limited to cyanosis, which does not cause any health problems. However, in rare cases, severe methemoglobinemia, beta-globin type can cause headaches, weakness, and fatigue.

Sickle cell disease

Sickle cell anemia (also called homozygous sickle cell disease or HbSS disease) is the most common form of sickle cell disease. This form is caused by a particular variant in the HBB gene that results in the production of an abnormal version of beta-globin called hemoglobin S (HbS). In people with this condition, hemoglobin S replaces both beta-globin subunits in hemoglobin.

The variant that causes hemoglobin S changes a single protein building block (amino acid) in beta-globin. Specifically, the amino acid glutamic acid is replaced with the amino acid valine at position 6 in beta-globin, written as Glu6Val (E6V). Replacing glutamic acid with valine causes the abnormal hemoglobin S subunits to stick together and form long, rigid molecules that bend red blood cells into a sickle or crescent shape. The sickle-shaped cells die too early, which can lead to a shortage of red blood cells (anemia). The rigid sickle-shaped cells can block small blood vessels, causing severe pain and organ damage.

Variants in the HBB gene can also cause other abnormalities in beta-globin, leading to other types of sickle cell disease. In these other types of sickle cell disease, just one beta-globin subunit is replaced with hemoglobin S. The other beta-globin subunit is replaced with a different version of beta-globin, such as hemoglobin C (HbC) or hemoglobin E (HbE).

In hemoglobin SC (HbSC) disease, the beta-globin subunits are replaced by hemoglobin S and hemoglobin C. Hemoglobin C occurs when the amino acid lysine replaces glutamic acid at position 6 in beta-globin (written as Glu6Lys or E6K). The severity of hemoglobin SC disease varies, but it can be as severe as sickle cell anemia. Hemoglobin E occurs when glutamic acid is replaced with lysine at position 26 in beta-globin (written as Glu26Lys or E26K). In some cases, hemoglobin E is present with hemoglobin S. In these cases, a person may have more severe signs and symptoms that are similar to those seen in people with sickle cell anemia, such as episodes of pain, anemia, and abnormal spleen function.

Another condition, known as hemoglobin S-beta thalassemias (HbSBetaThal), is caused when the variants that result in hemoglobin S and beta thalassemia occur together. Variants that combine sickle cell disease with beta-zero (β0) thalassemia lead to severe disease, while sickle cell disease combined with beta-plus (β+) thalassemia is generally milder.

Other disorders

Hundreds of variants have been identified in the HBB gene. These changes result in the production of different versions of beta-globin. Some of these variants cause no noticeable signs or symptoms and are found when blood work is done for other reasons, while other HBB gene variants may affect a person's health. Two of the most common alternative versions of beta-globin are hemoglobin C and hemoglobin E.

Hemoglobin C, caused by the Glu6Lys change in beta-globin, is more common in people of West African descent than in other populations. People who have two hemoglobin C subunits in their hemoglobin, instead of normal beta-globin, have a mild condition called hemoglobin C disease. This condition often causes chronic anemia, in which the red blood cells are broken down prematurely.

Hemoglobin E, caused by the Glu26Lys change in beta-globin, is most commonly found in the Southeast Asian population. When a person has two hemoglobin E subunits in their hemoglobin in place of beta-globin, a mild anemia called hemoglobin E disease can occur. In some cases, the variants that produce hemoglobin E and beta thalassemia are found together. People with this hemoglobin combination can have signs and symptoms ranging from mild anemia to severe thalassemia major.

Other Names for This Gene

beta globin
beta-globin
HBB_HUMAN
hemoglobin beta gene
hemoglobin, beta
hemoglobin--beta locus

Genomic Location

The HBB gene is found on chromosome 11.